Optimizing locoregional control and survival for women with breast cancer: a review of current developments in postmastectomy radiotherapy
Authors:
- Pauline T TruongPTPauline T Truong
- Wendy A WoodwardWWWendy A Woodward
- Thomas A BuchholzTBThomas A Buchholz
- 1 February 2006
- journal article
- review article
- Published by Taylor & Francis in Expert Review of Anticancer Therapy
- Vol. 6 (2) , 205-216
Abstract
For women who opt for mastectomy as primary surgery in breast cancer, indications for adjuvant radiotherapy are also being redefined in light of evidence demonstrating that postmastectomy radiotherapy (PMRT), when given in conjunction with systemic therapy, improves, not only locoregional control, but also survival. However, in certain settings, particularly in patients wih intermediate-risk disease, and in some patients treated with neoadjuvant chemotherapy, the role of PMRT remains controversial. Here, the authors review modern data pertaining to the benefits and risks of PMRT and discuss controversies related to the indications for PMRT, focusing on patients with T1-2 breast cancer with 0-3 positive nodes and patients treated with neoadjuvant chemotherapy. They also summarize key issues related to the integration of PMRT with other treatment modalities.Keywords
This publication has 57 references indexed in Scilit:
- Risk of Cardiac Death After Adjuvant Radiotherapy for Breast CancerJNCI: Journal of the National Cancer Institute, 2005
- Locoregional Radiation Therapy in Patients With High-Risk Breast Cancer Receiving Adjuvant Chemotherapy: 20-Year Results of the British Columbia Randomized TrialJNCI: Journal of the National Cancer Institute, 2005
- Postmastectomy Radiation Improves Local-Regional Control and Survival for Selected Patients With Locally Advanced Breast Cancer Treated With Neoadjuvant Chemotherapy and MastectomyJournal of Clinical Oncology, 2004
- Clinically Relevant Pneumonitis After Sequential Paclitaxel-Based Chemotherapy and Radiotherapy in Breast Cancer PatientsJNCI: Journal of the National Cancer Institute, 2004
- Patterns of Locoregional Failure in Patients With Operable Breast Cancer Treated by Mastectomy and Adjuvant Chemotherapy With or Without Tamoxifen and Without Radiotherapy: Results From Five National Surgical Adjuvant Breast and Bowel Project Randomized Clinical TrialsJournal of Clinical Oncology, 2004
- Risk Factors for Locoregional Recurrence Among Breast Cancer Patients: Results From International Breast Cancer Study Group Trials I Through VIIJournal of Clinical Oncology, 2003
- Predictors of Local-Regional Recurrence After Neoadjuvant Chemotherapy and Mastectomy Without RadiationJournal of Clinical Oncology, 2002
- Determinants of Patient Satisfaction in Postmastectomy Breast ReconstructionPlastic and Reconstructive Surgery, 2000
- Late Treatment-Related Morbidity in Breast Cancer Patients Randomized to Postmastectomy Radiotherapy and Systemic Treatment Versus Systemic Treatment AloneActa Oncologica, 2000
- Radiotherapy-Related Lung Fibrosis Enhanced by TamoxifenJNCI: Journal of the National Cancer Institute, 1996